Price
$1.08
Change
-$0.01 (-0.92%)
Updated
Jun 2, 6:59 PM EST
GET INTRADAY SIGNALS
61 days until earnings call
Price
$124.20
Change
+$7.36 (+6.30%)
Updated
Jun 2, 6:59 PM EST
GET INTRADAY SIGNALS
65 days until earnings call

Compare trend and price ADAP vs KRYS

Header iconADAP vs KRYS Comparison
Open Charts ADAP vs KRYSBanner chart's image
Adaptimmune Therapeutics
Price$1.08
Change-$0.01 (-0.92%)
Volume$654K
CapitalizationN/A
GET INTRADAY SIGNALS
Krystal Biotech
Price$124.20
Change+$7.36 (+6.30%)
Volume$183.33K
CapitalizationN/A
GET INTRADAY SIGNALS
View a ticker or compare two or three
ADAP vs KRYS Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ADAP vs. KRYS commentary
Jun 03, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAP is a Buy and KRYS is a StrongBuy.

COMPARISON
Comparison
Jun 03, 2023
Stock price -- (ADAP: $1.08 vs. KRYS: $124.20)
Brand notoriety: ADAP and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAP: 164% vs. KRYS: 133%
Market capitalization -- ADAP: $178.96M vs. KRYS: $3.2B
ADAP [@Biotechnology] is valued at $178.96M. KRYS’s [@Biotechnology] market capitalization is $3.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $353.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAP’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • ADAP’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than ADAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAP’s TA Score shows that 4 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • ADAP’s TA Score: 4 bullish, 6 bearish.
  • KRYS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than ADAP.

Price Growth

ADAP (@Biotechnology) experienced а -2.70% price change this week, while KRYS (@Biotechnology) price change was +3.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.24%. For the same industry, the average monthly price growth was +40.34%, and the average quarterly price growth was +51.56%.

Reported Earning Dates

ADAP is expected to report earnings on Aug 03, 2023.

KRYS is expected to report earnings on Aug 07, 2023.

Industries' Descriptions

@Biotechnology (+2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ADAP with price predictions.
OPEN
A.I.dvisor published
a Summary for KRYS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KRYS($3.2B) has a higher market cap than ADAP($179M). KRYS YTD gains are higher at: 56.779 vs. ADAP (-26.027). ADAP has higher annual earnings (EBITDA): -102M vs. KRYS (-147.33M). KRYS has more cash in the bank: 350M vs. ADAP (166M). KRYS has less debt than ADAP: KRYS (8.76M) vs ADAP (22.8M). ADAP has higher revenues than KRYS: ADAP (71.2M) vs KRYS (0).
ADAPKRYSADAP / KRYS
Capitalization179M3.2B6%
EBITDA-102M-147.33M69%
Gain YTD-26.02756.779-46%
P/E RatioN/AN/A-
Revenue71.2M0-
Total Cash166M350M47%
Total Debt22.8M8.76M260%
FUNDAMENTALS RATINGS
ADAP: Fundamental Ratings
ADAP
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAPKRYS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 20 days ago
83%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAADX9.970.34
+3.53%
Morgan Stanley Inst Dynamic Value R6
FAOCX27.270.21
+0.78%
Fidelity Advisor® Overseas C
COMVX3.74N/A
N/A
Comstock Capital Value AAA
INGIX17.46N/A
N/A
Voya US Stock Index Port I
UIVAX16.27N/A
N/A
Victory Value Institutional

ADAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with ADPT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAP
1D Price
Change %
ADAP100%
-0.92%
ADPT - ADAP
44%
Loosely correlated
+5.82%
MNKD - ADAP
37%
Loosely correlated
-0.45%
ORMP - ADAP
36%
Loosely correlated
-2.90%
CYTK - ADAP
36%
Loosely correlated
+1.77%
AGIO - ADAP
36%
Loosely correlated
+1.32%
More